Article Versions Notes

Kuźniewska A, Majeranowski A, Henry S, Kowalska D, Stasiłojć G, Urban A, Zaucha JM, Okrój M. The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab. Cancers. 2024; 16(1):49. https://doi.org/10.3390/cancers16010049

Kuźniewska, Alicja, Alan Majeranowski, Sara Henry, Daria Kowalska, Grzegorz Stasiłojć, Aleksandra Urban, Jan M. Zaucha, and Marcin Okrój. 2024. "The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab" Cancers 16, no. 1: 49. https://doi.org/10.3390/cancers16010049

Kuźniewska, A., Majeranowski, A., Henry, S., Kowalska, D., Stasiłojć, G., Urban, A., Zaucha, J. M., & Okrój, M. (2024). The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab. Cancers, 16(1), 49. https://doi.org/10.3390/cancers16010049